Credit Suisse »

Immunovant shares owned by Credit Suisse

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Credit Suisse

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 68k 32.31
2023-12-31 $2.4M 56k 42.13
2023-09-30 $2.2M 56k 38.39
2023-06-30 $1.2M 63k 18.97
2023-03-31 $782k 50k 15.51
2022-12-31 $868k 49k 17.75
2022-09-30 $224k 40k 5.56
2022-06-30 $147k 37k 3.97
2022-03-31 $186k 35k 5.33
2021-12-31 $200k 24k 8.53
2021-09-30 $182k 21k 8.47
2021-06-30 $727k 69k 10.59
2021-03-31 $1.0M 48k 20.83
2020-12-31 $2.1M 66k 32.26
2020-09-30 $1.6M 39k 41.67
2020-06-30 $325k 13k 24.32